Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy
Calliditas Therapeutics has announced positive topline results from the global, randomized, double-blind, placebo-controlled Phase 3 […]
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
Sumitovant Biopharma and Myovant Sciences announced today that Sumitovant has successfully completed its acquisition of […]
Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors
Diamyd Medical today announced that Karin Rosén will join the Board of Directors as an […]
Katsuyuki Takeuchi, Terumo, on Medical Care Solutions
In this video, Katsuyuki Takeuchi, the Global Product Manager at Terumo Pharmaceutical Solutions, discusses the […]
LivaNova Receives FDA Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
LivaNova, a market-leading medical technology and innovation company, today announced it received United States Food […]
Transgene Appoints John C. Bell and Pedro Romero as Key Scientific Advisors
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, […]
AusperBio Announces First-in-Human Dosing of AHB-137, an Antisense Oligonucleotide Drug Candidate for the Treatment of Chronic Hepatitis B
AusperBio has announced the completion of the first cohort dosing in a Phase 1 clinical […]
Cell One Partners and Center for Breakthrough Medicines Announce Strategic Partnership to Accelerate Cell and Gene Therapy Commercialization
Cell One Partners, an industry-leading strategic consulting firm positioned to support cell and gene therapy […]
Lena Wagner & Simone Marquardt, Raumedic, on Components for the Pharmaceutical and MedTech Industries
In this video, Lena Wagner and Simone Marquardt from Raumedic discuss the components that the […]
Allorion Therapeutics Raises $50 Million Series B Financing
Allorion Therapeutics, a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more